AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
Curreen Capital Partners Q3 2025 Letter: Enhabit Sale, New Investments in Kontoor and More
ByAinvest
Sunday, Oct 26, 2025 11:21 am ET1min read
Curreen Capital Partners' Q3 2025 letter reports a 9% return, with the sale of Enhabit shares to invest in Computacenter, Fortrea, VF Corp, 4imprint, Kontoor, Thinkific, Pluxee, and GetBusy. The decision to sell Enhabit was based on increasing headwinds facing the business, including proposed Medicare home health reimbursement rate cuts. The proceeds were used to invest in other companies with more favorable prospects. Kontoor was bought with proceeds from selling Credit Acceptance, with the Helly Hansen acquisition seen as a positive development.
Ainvest News articles are AI-generated using advanced large language model (LLM) technology designed to analyze and synthesize publicly available data and news. While AI tools assist in producing initial drafts and insights, all AI generated content published on Ainvest is subject to comprehensive human editorial review before publication. A designated human editor reviews, verifies, and approves each article for factual accuracy, coherence, and compliance with AInvest Fintech Inc’s editorial and disclosure standards.
Despite these review procedures, the information provided may still contain inaccuracies, incomplete data, or time sensitive references due to the inherent limitations of AI generated analysis and evolving changes. The material is provided strictly for informational and educational purposes and does not constitute personalized investment, legal, or financial advice. Readers should independently verify all facts, figures, and statements before making any decision based on this content.
AInvest Fintech Inc. its affiliates, and partners accept no liability or responsibility for any direct or consequential losses arising from reliance on this content. All articles and analyses are subject to revision, update, or removal without prior notice to maintain accuracy and integrity in our publications.
Comments
No comments yet